Trial Profile
A Study of Apatinib in Combination With Chemotherapy Versus Chemotherapy Alone for Advanced Ovarian Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Carboplatin; Cisplatin; Docetaxel; Paclitaxel
- Indications Carcinoma; Fallopian tube cancer; Ovarian cancer
- Focus Therapeutic Use
- 07 Jan 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified January 2018).
- 12 Jan 2018 New trial record